eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Get Medicines Compendium UK app here

Thornton & Ross Ltd

Telephone: +44 (0)1484 842217
Fax: +44 (0)1484 847301
WWW: http://www.thorntonandross.com
Medical Information Direct Line: +44(0)1484 848 251
Medical Information e-mail: phv@thorntonross.co.uk
Customer Care direct line: +44(0)1484 842 217
Medical Information Fax: +44(0)1484 847 301

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?


Summary of Product Characteristics last updated on the eMC: 10/11/2011
SPC Gee's Linctus BP


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Gee's Linctus BP or Opiate Squill Linctus BP


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Opium Tincture 0.083ml per 5ml.

Squill Oxymel 1.667ml per 5ml.

For excipients, see 6.1


Go to top of the page
3. PHARMACEUTICAL FORM

Oral solution.

A straw coloured to light brown opalescent or turbid liquid.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For relief of the symptoms of coughs.


Go to top of the page
4.2 Posology and method of administration

Oral.

Recommended doses

Adults and children over 12 years: 5ml.

Children under 12 years: Not recommended.

The elderly: Use with care, not exceeding the recommended adult dose.

Dosage schedule

The dose may be repeated after 4 hours if required but not more than 4 doses in any 24 hours.

If symptoms persist for more than 7 days consult a doctor.


Go to top of the page
4.3 Contraindications

Contraindicated in patients with known hypersensitivity to any of the ingredients. Also contraindicated in patients with cardiac disorders and in impaired hepatic or renal function.

Contraindicated in cases of moderate to severe respiratory depression, alcoholism, head injuries and conditions in which intracranial pressure is raised, also in acute asthma, and heart failure secondary to chronic lung disease.

Contraindicated in patients receiving treatment with monoamine oxidase inhibitors or within 14 days of stopping such treatment.


Go to top of the page
4.4 Special warnings and precautions for use

The linctus should be given with caution to patients with: hypothyroidism, adrenocortical insufficiency, inflammatory or obstructive bowel disorders, prostatic hypertrophy, shock, myasthenia gravis, hypotension, the elderly and patients with general debilitation. Reduced doses may be required in these conditions.

Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine.

Warnings to appear on labels:

Do not exceed the stated dose.

Recommended diluent: syrup BP

Keep out of the reach and sight of children.

If symptoms persist for more than 7 days consult a doctor.

Do not take if allergic to any of the ingredients, have heart, liver or kidney disease, or breathing difficulty or suffer from alcoholism or raised pressure in the head.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

The linctus should not be taken by patients receiving monoamine-oxidase inhibitors or within 14 days of stopping such treatment.

Narcotic analgesics cause delayed absorption of mexiletine, they also cause potentiation of the effects of hypnotics and anxiolytics and other CNS depressants. They have opposing effects on gastro-intestinal activity to domperidone and metoclopramide. Toxicity of squill glycosides may be increased when given in combination with thiazides or loop diuretics, as these cause hypokalaemia and hypomagnesaemia which may lead to cardiac arrhythmias.

Hypokalaemia may result from simultaneous treatment with corticosteroids, amphotericin, sodium polystyrene sulphonate and carbenoxolone.

Absorption may be affected by intestinal absorptive agents and antacids including metoclopramide and propantheline. Simultaneous administration of spironolactone, phenobarbital or rifampicin may reduce renal excretion.


Go to top of the page
4.6 Pregnancy and lactation

Should be used with caution if at all during pregnancy and lactation.


Go to top of the page
4.7 Effects on ability to drive and use machines

At the recommended dose the linctus is unlikely to cause drowsiness, however, if affected do not drive or operate machinery.


Go to top of the page
4.8 Undesirable effects

Narcotic analgesics may cause nausea, vomiting, constipation, drowsiness, confusion. Larger doses may cause respiratory depression, difficulty with micturition, urticaria, pruritis, flushing and hypotension. Tolerance gradually develops with long term use although not constipation, and dependence is liable to be caused. Squill contains cardiac glycosides and may cause nausea, vomiting and anorexia, diarrhoea and abdominal pain may also occur.


Go to top of the page
4.9 Overdose

Signs of morphine overdosage include pin-point pupils, depressed respiration, circulatory failure, pulmonary oedema, convulsions, renal failure and coma. Gastric lavage should be performed as soon as possible after ingestion, and intensive supportive therapy carried out. Naloxone may be given as an antidote (initially 0.8 – 2.0 mg, to a maximum of 10mg, by intravenous injection).

Common symptoms of digoxin overdosage are headache, facial pain, fatigue, weakness, dizziness, drowsiness, disorientation, mental confusion, bad dreams and more rarely delirium, acute psychoses, and hallucinations. Visual disturbances including blurred and misted vision may occur. Colour vision may be affected with objects appearing yellow or occasionally green, red, brown, blue or white. Convulsions have been reported.

Large doses of squill produce nausea, vomiting and diarrhoea, it has a digitalis-like effect on the heart. Supraventricular or ventricular arrhythmias and defects of conduction may be an early indication of excessive dosage.

Treatment of acute digoxin poisoning consists of emptying the stomach by emesis or aspiration and lavage. Activated charcoal may be given. Cardiac toxicity should be treated under ECG control and serum electrolytes should be monitored. Anti-arrhythmic treatment may be necessary and should be determined by the specific arrhythmia present. Atropine may be given intravenously to control bradycardia, and in patients with heart block; cardiac pacing may be necessary if atropine is not effective. Colestyramine or colestipol may be of use in increasing the elimination of cardiac glycosides.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

R05F A02 – Cough suppressants and expectorants, combinations – opium derivatives and expectorants

Morphine and other related opioids are effective for the suppression of cough. They depress the cough reflex, at least in part by a direct effect on a cough centre in the medulla.

Squill has an irritant effect on the gastric mucosa, it has a reflex expectorant action.


Go to top of the page
5.2 Pharmacokinetic properties

Opioids are readily absorbed from the gastrointestinal tract. The major pathway for detoxification of morphine is conjugation with glucuronic acid. Small amounts of free morphine and larger amounts of conjugated morphine are excreted in the urine, accounting for most of the administered drug. 90% of total excretion occurs during the first day, however, traces may be detectable in the urine for over 48 hours. The major route of elimination of the metabolites is by glomerular filtration. 7 – 10% of administered morphine eventually appears in the faeces, this comes mostly from the bile as conjugated morphine.

Enterohepatic circulation of morphine and morphine glucuronide occurs, this accounts for the presence of morphine in the urine several days after the last dose.

Squill glycosides are poorly absorbed from the gastrointestinal tract, they are of short acting duration and are not cumulative. The drug promotes mild gastric irritation, causing a reflex secretion from the bronchioles.


Go to top of the page
5.3 Preclinical safety data

No data of relevance to the prescriber, which is additional to that included in other sections of the SPC.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Anise oil

Benzoic Acid

Camphor

Ethanol (96%)

Purified Water

Tolu flavour solution

Syrup


Go to top of the page
6.2 Incompatibilities

No major incompatibilities known.


Go to top of the page
6.3 Shelf life
 

100ml

36 months unopened.

200ml:

36 months unopened.

500ml:

36 months unopened.

2000ml:

36 months unopened.


Go to top of the page
6.4 Special precautions for storage

Store below 25°C.


Go to top of the page
6.5 Nature and contents of container

100ml:

amber glass bottle with polypropylene cap or white 28mm cap with tamper evident band and EPE Saranex liner

200ml:

amber glass bottle with polypropylene cap or white 28mm cap with tamper evident band and EPE Saranex liner

500ml:

amber glass bottle and plastic cap with liner or white 28mm cap with tamper evident band and EPE Saranex liner.

2000ml:

polythene bottle and plastic cap with liner.


Go to top of the page
6.6 Special precautions for disposal and other handling

None.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

L.C.M. Ltd

Linthwaite Laboratories

Huddersfield

HD7 5QH


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 12965/0034


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

24.03.94


Go to top of the page
10. DATE OF REVISION OF THE TEXT

August 2004


Go to top of the page
11 DOSIMETRY

Not Applicable


Go to top of the page
12 INSTRUCTIONS FOR PREPARATION OF RADIOPHARMACEUTICALS

Not Applicable



More information about this product

Link to this document from your website: http://www.medicines.org.uk/emc/medicine/25267/SPC/


Active Ingredients/Generics

 
   opium tincture
   squill oxymel